Table 2.

Patient demographics, clinical and interventional parameters of group^hemihep and group^noresection

Patients	Primary malignancy	Age at first CS-PHP (years)	Sex	Number of CS-PHP	LDH (U/I) previous to first CS-PHP	Hemi- hepatectomy until first CS-PHP (months)	Initial diagnosis until first CS-PHP (months)
grouphemihep
1	iCCC	60	m	5	206	27	27
2	iCCC	59	m	1	376	13	13
3	iCCC	39	m	1	320	16	16
4	iCCC	61	f	1	233	77	78
5	iCCC	36	f	7	380	4	5
6	UM	49	f	4	230	8	83
7	UM	55	m	2	1559	90	262
groupnoresection
1	iCCC	75	m	5	283	n.a	35
2	iCCC	81	m	2	382	n.a	10
3	iCCC	62	m	2	224	n.a	42
4	iCCC	61	f	4	233	n.a	12
5	iCCC	53	f	4	238	n.a	8
6	UM	46	f	4	242	n.a	44
7	UM	57	f	1	1064	n.a	42
grouphemihep	71% iCCC 29% UM	52 ± 10 **	43% f 57% m	21 interventions in total	320 (232–378) *	10.5 (16–52)*	27 (14.5–80.5)*
groupnoresection	71% iCCC 29% UM	63 ± 12 **	57% f 43% m	22 interventions in total	242 (236–333) *	n.a	35 (11–42)*
p-value		0.14		0.74	0.95		0.5

iCCC  intrahepatic cholangiocarcinoma, f  female, LDH   lactate dehydrogenase, M   male, UM   uveal melanoma

*Values are presented in median and interquartile range, **Values are presented in mean and standard deviation